簡(jiǎn)要描述:共濟(jì)失調(diào)性眼球運(yùn)動(dòng)功能喪失相關(guān)蛋白AOA1抗體免 疫 原;KLH conjugated synthetic peptide derived from human Aprataxin: 221-320/356
產(chǎn)品分類(lèi)
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
共濟(jì)失調(diào)性眼球運(yùn)動(dòng)功能喪失相關(guān)蛋白AOA1抗體
產(chǎn)品名稱(chēng) | 英文名稱(chēng) | 貨號(hào) |
共濟(jì)失調(diào)性眼球運(yùn)動(dòng)功能喪失相關(guān)蛋白AOA1抗體 | Aprataxin | GOY-01K2548 |
商品屬性:
英文名稱(chēng): Aprataxin
中文名:共濟(jì)失調(diào)性眼球運(yùn)動(dòng)功能喪失相關(guān)蛋白AOA1抗體
別 名;AOA 1; AOA; AOA;
AOA1; AOA1; Aprataxin; Aprataxin; Aprataxin homolog; APTX; APTX; APTX_HUMAN;
Ataxia 1 early onset with hypoalbuminemia; Ataxia 1 early onset with hypoalbuminemia;
Ataxia1 early onset with hypoalbuminemia; AXA 1; AXA1; AXA1; EAOH; EAOH; EOAHA;
EOAHA; FHA HIT; FHA HIT; FHA-HIT; FLJ20157; FLJ20157; Forkhead associated
domain histidine triad like; Forkhead associated domain histidine triad like;
Forkhead associated domain histidine triad like protein; Forkhead-associated
domain histidine triad-like protein; MGC1072; MGC1072.
抗體來(lái)源;Rabbit
克隆類(lèi)型;Polyclonal
交叉反應(yīng);(predicted:
Human, Mouse, Rat, Horse, Rabbit, Sheep, )
產(chǎn)品應(yīng)用;ELISA=1:5000-10000
IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
理論分子量;41kDa
細(xì)胞定位;細(xì)胞核
性 狀;Liquid
濃 度;1mg/ml
免 疫 原;KLH
conjugated synthetic peptide derived from human Aprataxin: 221-320/356
亞 型;IgG
純化方法;affinity
purified by Protein A
緩 沖 液;0.01M
TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件;Shipped at
4℃. Store at -20 °C for one
year. Avoid repeated freeze/thaw cycles.
產(chǎn)品介紹:
Aprataxin is a nuclear protein, present in both
the nucleoplasm and the nucleolus, which is a member of the histidine triad
(HIT) superfamily. Aprataxin is involved in DNA single-strand break repair,
mediating protein-protein interactions with molecules responding to DNA
damage. Aprataxin contains three conserved domains: an N-terminal
forkhead-associated (FHA) domain which mediates protein-protein interactions,
a HIT domain that is similar to Hint, and a C-terminal zinc finger domain.
Loss of function mutations in APTX, the gene encoding for Aprataxin,
destabilize the Aprataxin protein and result in a rare neurological disorder
known as ataxia-oculomotor apraxia, characterized by abnormal movements of
the head and eyes. These mutations either target the HIT domain or truncate
the protein N-terminal to a zinc finger. Function: |
多克隆抗體制備:
我公司合成抗原,保證陽(yáng)性血清和抗體ELISA效價(jià)達(dá)到1:32000,由蛋白抗原制備的多抗,保證WB檢測(cè)結(jié)果是陽(yáng)性。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶(hù)節(jié)約成本。
鼠單克隆抗體制備:
客戶(hù)可根據(jù)項(xiàng)目實(shí)際需求情況靈活選擇進(jìn)行,我公司將為您的項(xiàng)目提供專(zhuān)業(yè)的建議。在制備過(guò)程中,與客戶(hù)互動(dòng)驗(yàn)證,確保最終制備的抗體ELISA陽(yáng)性血清檢測(cè)達(dá)到合同要求的同時(shí),也能滿(mǎn)足客戶(hù)抗體最終應(yīng)用驗(yàn)證需求。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶(hù)節(jié)約成本。
重組抗體表達(dá)服務(wù):
重組抗體技術(shù)使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無(wú)法做到的。我公司已搭建好的抗體測(cè)序、重組抗體表達(dá)等先進(jìn)平臺(tái),能為客戶(hù)提供各種類(lèi)型的重組抗體表達(dá)服務(wù),包含鼠源單克隆抗體構(gòu)建及表達(dá)、更換恒定區(qū)亞型的嵌合抗體表達(dá),抗體人源化改造及表達(dá)等服務(wù)。
單項(xiàng)免疫學(xué)及檢測(cè)服務(wù):
我公司也為客戶(hù)提供單項(xiàng)免疫學(xué)和檢測(cè)服務(wù),如動(dòng)物免疫、動(dòng)物飼養(yǎng)、抗體修飾服務(wù)(如FITC,HRP等的標(biāo)記)、以及ELISA,WB,IHC,DB等檢測(cè)服務(wù)。
抗體定制服務(wù):
已注冊(cè)商標(biāo),主要用于抗體藥物發(fā)現(xiàn)和開(kāi)發(fā),是我公司針對(duì)有特定應(yīng)用要求和各種模型測(cè)試的客戶(hù)量身定制的專(zhuān)業(yè)服務(wù),主要面向工業(yè)客戶(hù)。
產(chǎn)品咨詢(xún)
歡迎您關(guān)注我們的微信了解更多信息
電話(huà)
微信掃一掃